+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 86 Pages
  • November 2020
  • Region: Global
  • GlobalData
  • ID: 5212340
Summary

The publisher's Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hepatitis Viruses Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Hepatitis B and C.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hepatitis Viruses Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hepatitis Viruses Rapid Tests & POC Overview
3 Products under Development
3.1 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
3.3 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
5 Hepatitis Viruses Rapid Tests & POC Companies and Product Overview
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
Table 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 6: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
Table 9: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
Table 10: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: PIFA Hep B / Hep C - Product Status
Table 12: PIFA Hep B / Hep C - Product Description
Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Alere q Analyzer - HCV VL Assay - Product Status
Table 15: Alere q Analyzer - HCV VL Assay - Product Description
Table 16: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Rapid Immunoassay - HCV - Product Status
Table 18: Rapid Immunoassay - HCV - Product Description
Table 19: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: AtomoRapid - Hepatitis C - Product Status
Table 21: AtomoRapid - Hepatitis C - Product Description
Table 22: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Idylla Viral Load Assay - HBV - Product Status
Table 24: Idylla Viral Load Assay - HBV - Product Description
Table 25: Idylla Viral Load Assay - HCV - Product Status
Table 26: Idylla Viral Load Assay - HCV - Product Description
Table 27: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: INSTI Test - Hepatitis C - Product Status
Table 29: INSTI Test - Hepatitis C - Product Description
Table 30: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Spinit Device - Hepatitis C Biomarker Assay - Product Status
Table 32: Spinit Device - Hepatitis C Biomarker Assay - Product Description
Table 33: Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Kit - Hepatitis A - Product Status
Table 35: Diagnostic Kit - Hepatitis A - Product Description
Table 36: Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: ATR-FTIR System - Hepatitis B & C - Product Status
Table 38: ATR-FTIR System - Hepatitis B & C - Product Description
Table 39: Blink AG Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
Table 41: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
Table 42: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Paper Based Test - HBV - Product Status
Table 44: Paper Based Test - HBV - Product Description
Table 45: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: GeneXpert Omni - HCV Viral Load - Product Status
Table 47: GeneXpert Omni - HCV Viral Load - Product Description
Table 48: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: DPP Hepatitis C Virus Assay - Product Status
Table 50: DPP Hepatitis C Virus Assay - Product Description
Table 51: Next Generation DPP HCV Assay - Product Status
Table 52: Next Generation DPP HCV Assay - Product Description
Table 53: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Diagnostic Assay - Hepatitis C - Product Status
List of Figures
Figure 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diagnostics
  • Akers Biosciences Inc
  • Alere Inc
  • Arkray Inc
  • Atomo Diagnostics Ltd
  • Biocartis Group NV
  • bioLytical Laboratories Inc
  • Biosurfit, SA
  • Biotech Consortium India Ltd
  • Biotech Resources Aust Pty Ltd
  • Blink AG
  • Boston University
  • Cepheid Inc
  • Chembio Diagnostic Systems Inc
  • ChipCare Corp
  • Correlia Biosystems, Inc.
  • CoSara Diagnostics Pvt Ltd
  • Daktari Diagnostics, Inc.
  • DCN Diagnostics
  • Diagnostics For All Inc
  • Diagnostics for the Real World Ltd
  • Fast Track Diagnostics Ltd
  • Group K Diagnostics
  • ImmunoScience Inc
  • MedMira Inc
  • Micronics Inc
  • Mologic Ltd
  • NanoComposix Inc
  • NanoRepro AG
  • NOWDiagnostics Inc
  • Quidel Corp
  • SLS Cell Cure Technologies Pty Ltd
  • University of California Irvine
  • Wave 80 Biosciences Inc
  • Xagenic Inc